Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 750 of 2873 entries
View as:

PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP

Phase: N/A Priority: Normal
NCT ID: NCT00088231 Org: User:
Start: 07/31/04 End: 10/31/06 Due: 10/31/07

Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia

Phase: N/A Priority: Normal
NCT ID: NCT05060328 Org: User:
Start: 06/22/21 End: 03/22/22 Due: 03/22/23

Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04513990 Org: User:
Start: 04/09/20 End: 04/30/23 Due: 04/30/24

Parenteral Hydration in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00423722 Org: User:
Start: 01/09/07 End: 05/31/13 Due: 05/31/14

Hysteroscopic Lymphatic Mapping for Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00671606 Org: User:
Start: 04/30/08 End: 06/30/10 Due: 06/30/11

Thalidomide for Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00038233 Org: User:
Start: 05/31/99 End: 04/30/05 Due: 04/30/06

Wearable Exercise Trackers in Cancer Rehabilitation

Phase: N/A Priority: Normal
NCT ID: NCT03042884 Org: User:
Start: 02/13/17 End: 12/14/20 Due: 12/14/21

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06408168 Org: User:
Start: 08/08/24 End: 12/31/27 Due: 12/31/28

Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03541902 Org: User:
Start: 05/15/18 End: 07/31/25 Due: 07/31/26

Molecular Triaging of Newly Diagnosed Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01159236 Org: User:
Start: 09/30/10 End: - Due: -

Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02530463 Org: User:
Start: 09/08/15 End: 09/30/25 Due: 09/30/26

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT05174026 Org: User:
Start: 11/30/18 End: 06/20/24 Due: 06/20/25

Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits

Phase: N/A Priority: Normal
NCT ID: NCT03856060 Org: User:
Start: 03/30/19 End: 08/30/24 Due: 08/30/25

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02530489 Org: User:
Start: 02/04/16 End: 05/23/25 Due: 05/23/26

A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

Phase: N/A Priority: Normal
NCT ID: NCT05360160 Org: User:
Start: 10/14/22 End: 12/01/26 Due: 12/01/27

A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05044546 Org: User:
Start: 10/19/21 End: 03/31/26 Due: 03/31/27

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00880074 Org: User:
Start: 04/09/09 End: 02/04/22 Due: 02/04/23

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Phase: N/A Priority: Normal
NCT ID: NCT02210104 Org: User:
Start: 12/31/16 End: - Due: -

Prevention of Treatment Induced Neuropathy in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01283997 Org: User:
Start: 01/25/11 End: 08/22/22 Due: 08/22/23

IUdR/BUdR Cell Cycle Labelling

Phase: N/A Priority: Normal
NCT ID: NCT00042250 Org: User:
Start: 05/31/92 End: 10/31/02 Due: 10/31/03

Text Messages in Preventing Tobacco Use in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT03457480 Org: User:
Start: 09/20/13 End: 01/29/21 Due: 01/29/22

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00536978 Org: User:
Start: 09/30/07 End: 11/30/10 Due: 11/30/11

SINF: Peripheral Neuropathy in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT02168894 Org: User:
Start: 03/31/16 End: - Due: -

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00658281 Org: User:
Start: 03/31/08 End: 10/31/14 Due: 10/31/15

Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00499603 Org: User:
Start: 07/31/07 End: 04/30/17 Due: 04/30/18